受强制性开放获取政策约束的文章 - Katsutoshi Oda了解详情
可在其他位置公开访问的文章：6 篇
PIK3CA cooperates with other phosphatidylinositol 3′-kinase pathway mutations to effect oncogenic transformation
K Oda, J Okada, L Timmerman, P Rodriguez-Viciana, D Stokoe, K Shoji, ...
Cancer research 68 (19), 8127-8136, 2008
强制性开放获取政策： Howard Hughes Medical Institute
Genomics to immunotherapy of ovarian clear cell carcinoma: unique opportunities for management
K Oda, J Hamanishi, K Matsuo, K Hasegawa
Gynecologic oncology 151 (2), 381-389, 2018
强制性开放获取政策： US National Institutes of Health
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
I Vergote, A Gonzalez-Martin, D Lorusso, C Gourley, MR Mirza, JE Kurtz, ...
The Lancet Oncology 23 (8), e374-e384, 2022
强制性开放获取政策： US National Institutes of Health, Health Research Board, Ireland, National …
The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma
H Machino, S Kaneko, M Komatsu, N Ikawa, K Asada, R Nakato, K Shozu, ...
Communications Biology 5 (1), 39, 2022
强制性开放获取政策： US National Institutes of Health
Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer
F Inoue, K Sone, Y Toyohara, S Tanimoto, Y Takahashi, M Kusakabe, ...
Biochemical and Biophysical Research Communications 601, 123-128, 2022
强制性开放获取政策： US National Institutes of Health
Gynecological cancers translational, research implementation, and harmonization: Gynecologic Cancer InterGroup consensus and still open questions
M Bagnoli, TY Shi, C Gourley, P Speiser, A Reuss, HW Nijman, ...
Cells 8 (3), 200, 2019
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, UK Medical Research …
出版信息和资助信息由计算机程序自动确定